NCT02235480View on ClinicalTrials.gov

Efficacy and Safety of Tazarotene Gel in Nail Psoriasis

PHASE2CompletedINTERVENTIONAL
Enrollment

66

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

May 31, 2014

Study Completion Date

May 31, 2015

Conditions
Nail Psoriasis
Interventions
DRUG

Experimental Tazarotene Gel

DRUG

Placebo

Trial Locations (4)

Unknown

Investigational site 3, Berlin

Investigational site 4, Berlin

Investigational 2, Hamburg

Investigational site 1, Hamburg

Sponsors

Lead Sponsor

Almirall, S.A.
All Listed Sponsors
lead

Almirall, S.A.

INDUSTRY

NCT02235480 - Efficacy and Safety of Tazarotene Gel in Nail Psoriasis | Biotech Hunter | Biotech Hunter